Analytical Data
-
Gene name
TAFA5/FAM19A5
- Application
-
Alternative Names
TAFA-5; Chemokine-like protein TAFA-5
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z5A7
-
Expression Region
Thr44~Ser132
-
Molecular Weight
15kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAFA5, also known as FAM19A5, is a member of the TAFA family of proteins, which are characterized by their unique cysteine-rich motifs and are involved in various biological processes, including immune response and neuroprotection. Recent studies have highlighted the potential role of TAFA5 in modulating inflammation and promoting tissue repair, making it a subject of interest in both immunology and regenerative medicine. Research indicates that TAFA5 may interact with specific receptors and signaling pathways, contributing to its functional diversity. The recombinant expression of TAFA5 offers a valuable opportunity to investigate its mechanisms of action, protein interactions, and therapeutic potentials. Understanding the structure and function of this protein could pave the way for novel strategies in treating inflammatory diseases and enhancing wound healing. Additionally, the recombinant protein can serve as a tool for clinical diagnostics and the development of biomarker assays. Overall, studying TAFA5/FAM19A5 at the molecular level holds promise for uncovering new insights into its biological significance and therapeutic applications, thus contributing to advancements in medical research and treatment options.
